Onima Chowdhury
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).
Journal: Arthritis care & research
Published: March 05, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.
Journal: Journal of clinical medicine
Published: November 16, 2025
Establishing a consensus definition of VEXAS flare for clinical research.
Journal: Rheumatology (Oxford, England)
Published: July 31, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.
Journal: The Lancet. Rheumatology
Published: December 05, 2024
Low-risk MDS-A spotlight on precision medicine for SF3B1-mutated patients.
Journal: HemaSphere
Published: October 17, 2024
Multi-organ abnormalities assessed by a single MRI scan in individuals with blood cancer.
Journal: European journal of internal medicine
Published: April 17, 2024
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Journal: British journal of haematology
Published: June 16, 2021
Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.
Journal: The Journal of experimental medicine
Published: August 25, 2016
Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.
Journal: Cell death discovery
Published: November 17, 2015
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Journal: Cancer cell
Published: October 16, 2013
Oral deferiprone for iron chelation in people with thalassaemia.
Journal: The Cochrane database of systematic reviews
Published: August 23, 2013
Last Updated: 09/26/2026